Optimizing Cardiology Prior Authorization Automation for Cardiac Care

Klivira's cardiology prior authorization automation platform is purpose-built to navigate the unique complexities of cardiac care, ensuring timely approvals and reducing administrative burden.

For revenue cycle directors, prior authorization coordinators, and IT leads in cardiology, managing the volume and complexity of prior authorizations for cardiac services is a significant operational challenge. From advanced imaging to interventional procedures and specialty drugs, delays and denials directly impact patient access and revenue integrity. Klivira provides an end-to-end solution to automate these critical workflows.

The Unique Prior Authorization Landscape in Cardiology

Cardiology presents a high-volume, high-complexity prior authorization environment. Critical procedures, advanced diagnostics, and specialty medications often require pre-approval, leading to significant administrative overhead. The need for expedited pathways for urgent cases, coupled with the prevalence of specialty benefit-management vendors, further complicates manual workflows.

High-Volume Cardiology PA Triggers

**Advanced Cardiac Imaging:** Stress echo, nuclear stress imaging, cardiac MRI, cardiac CT angiography (CCTA), PET cardiac viability, often routed through specialty benefit-management vendors.
**Cardiac Catheterization & Interventional Procedures:** Diagnostic cardiac cath, percutaneous coronary intervention (PCI), structural-heart procedures like TAVR, MitraClip, and LAA closure.
**Electrophysiology Procedures:** Implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy (CRT-D, CRT-P), pacemakers, and ablation procedures (atrial fibrillation, ventricular tachycardia).
**Specialty Cardiovascular Drugs:** PCSK9 inhibitors, sacubitril/valsartan (Entresto), SGLT2 inhibitors for heart failure, mavacamten, and specific anticoagulants.

Navigating Cardiology-Specific Documentation and Denial Patterns

Successful prior authorization in cardiology hinges on meticulous documentation aligned with clinical guidelines such as ACC/AHA and ACR Appropriateness Criteria. Common denials stem from gaps in ejection fraction or NYHA class documentation for devices, failure to meet step therapy requirements for imaging, or non-adherence to optimal medical therapy duration for primary prevention ICDs. Klivira’s platform is built with these specific requirements and denial patterns in mind.

Klivira's Automated Workflow for Cardiology PA

Klivira integrates directly with your EMR to detect PA requirements at the point of order entry using CDS Hooks, preventing missed authorizations. For cardiology, this means immediate identification of PA needs for advanced imaging, interventional procedures, or specialty medications. The platform then automates the assembly of necessary clinical documentation, pulling FHIR resources from the EMR to meet payer-specific criteria, including those informed by ACR Appropriateness Criteria for imaging.

Intelligent Payer Connectivity and Denial Management

Our system routes cardiology PA requests through the most efficient channels—Da Vinci PAS API, X12 278, or provider portals—including automatic identification and routing to specialty benefit-management vendors like Carelon MBM or eviCore successor vendors. Real-time status tracking and automated write-back of authorization numbers to your EMR streamline operations. For denials, Klivira parses reasons, facilitates auto-appeals where possible, and guides human review or peer-to-peer scheduling for complex clinical-necessity cases, ensuring timely-filing windows are met.

Addressing Time-Sensitive and Complex Cardiology Cases

Cardiology often involves time-sensitive procedures and devices with longer PA lead times. Klivira’s workflow accounts for these nuances, supporting expedited PA pathways for urgent presentations like chest pain workups and managing the extended timelines for ICD/CRT/structural-heart device authorizations. Our platform also incorporates payer-specific step-therapy logic for specialty drugs, optimizing approval rates and reducing delays in accessing critical cardiovascular therapies.

Frequently asked questions

How does Klivira handle prior authorizations for advanced cardiac imaging?

Klivira automatically identifies advanced cardiac imaging orders (e.g., cardiac MRI, nuclear stress tests) at the point of entry. It then applies ACR Appropriateness Criteria-aware policy logic and routes the request to the correct channel, including specialty benefit-management vendors like Carelon MBM or eviCore successor vendors, ensuring all required documentation is submitted.

Can Klivira manage prior authorizations for high-cost cardiology devices like ICDs or CRT?

Yes, Klivira supports prior authorization workflows for cardiology devices such as ICDs, CRT-Ds, and pacemakers. Our system accounts for the typically longer lead times associated with device PAs and assists in assembling the necessary documentation, including ejection fraction, NYHA functional class, and optimal medical therapy duration, which are common requirements.

What EMR systems does Klivira integrate with for cardiology PA automation?

Klivira integrates with major EMR systems using SMART App Launch on FHIR for platforms like Epic, Cerner/Oracle Health, athenahealth, MEDITECH Expanse, eClinicalWorks, and Veradigm. We also support HL7 v2 interfaces for legacy environments and utilize CDS Hooks for real-time PA requirement detection at order entry.

How does Klivira address common cardiology PA denial reasons?

Klivira addresses common cardiology denial reasons by ensuring documentation aligns with payer policies and clinical guidelines. This includes verifying appropriate use criteria for imaging, adherence to step therapy, and accurate documentation of clinical specifics like ejection fraction or duration of guideline-directed medical therapy. For denials, the platform automates appeal packet assembly and tracks timely-filing windows.

Does Klivira automate prior authorizations for specialty cardiology drugs?

Absolutely. Klivira automates PA for specialty cardiology drugs such as PCSK9 inhibitors, sacubitril/valsartan, and SGLT2 inhibitors. The platform incorporates payer-specific step-therapy logic and documentation requirements, like LDL levels on maximum tolerated statins for PCSK9 inhibitors, to streamline submission and improve approval rates.